{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:22:02Z","timestamp":1794540122826,"version":"4.9.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24036-w","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:40:27Z","timestamp":1754325627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Global determinants of breast cancer mortality: a comprehensive meta-analysis of clinical, demographic, and lifestyle risk factors"],"prefix":"10.1186","volume":"25","author":[{"given":"Zelalem G.","family":"Dessie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Zewotir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"1","key":"24036_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","volume":"124","author":"AI Riggio","year":"2021","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124(1):13\u201326.","journal-title":"Br J Cancer"},{"issue":"6","key":"24036_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"24036_CR3","first-page":"399","volume":"22","author":"AI Phipps","year":"2011","unstructured":"Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control. 2011;22(3):399\u2013405.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"24036_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst. 2011;103(3):250\u201363.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"24036_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/1055-9965.EPI-20-0924","volume":"30","author":"A Morra","year":"2021","unstructured":"Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Culver H, Arndt V, Augustinsson A, Auvinen PK, Beane Freeman LE. Breast cancer risk factors and survival by tumor subtype: pooled analyses from the breast Cancer association consortium. Cancer Epidemiol Biomarkers Prev. 2021;30(4):623\u201342.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"24036_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0540-z","volume":"13","author":"A Prat","year":"2015","unstructured":"Prat A, Fan C, Fern\u00e1ndez A, Hoadley KA, Martinello R, Vidal M, Viladot M, Pineda E, Arance A, Mu\u00f1oz M. Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. BMC Med. 2015;13(1):1\u201311.","journal-title":"BMC Med"},{"issue":"1","key":"24036_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2766-3","volume":"16","author":"A Hennigs","year":"2016","unstructured":"Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marm\u00e9 F, J\u00e4ger D, Kauczor H-U, Stieber A, Lindel K. Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study. BMC Cancer. 2016;16(1):1\u20139.","journal-title":"BMC Cancer"},{"key":"24036_CR8","doi-asserted-by":"crossref","unstructured":"Tfayli A, Temraz S, Abou Mrad R, Shamseddine A. Breast cancer in low-and middle-income countries: an emerging and challenging epidemic. J Oncol. 2010:490631.","DOI":"10.1155\/2010\/490631"},{"issue":"1","key":"24036_CR9","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.14694\/EdBook_AM.2015.35.e31","volume":"35","author":"BD Lehmann","year":"2015","unstructured":"Lehmann BD, Pietenpol JA, Tan AR. Triple-negative breast cancer: molecular subtypes and new targets for therapy. Am Soc Clin Oncol Educational Book. 2015;35(1):e31\u20139.","journal-title":"Am Soc Clin Oncol Educational Book"},{"key":"24036_CR10","doi-asserted-by":"crossref","unstructured":"Shulman LN, Willett W, Sievers A, Knaul FM. Breast cancer in developing countries: opportunities for improved survival. J Oncol. 2010:595167.","DOI":"10.1155\/2010\/595167"},{"key":"24036_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.6061\/clinics\/2017(04)09","volume":"72","author":"RA da Costa Vieira","year":"2017","unstructured":"da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics. 2017;72:244\u201353.","journal-title":"Clinics"},{"key":"24036_CR12","doi-asserted-by":"crossref","unstructured":"Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. BioMed Res Int. 2022:9605439.","DOI":"10.1155\/2022\/9605439"},{"issue":"2","key":"24036_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2231-4040.72251","volume":"1","author":"GN Sharma","year":"2010","unstructured":"Sharma GN, Dave R, Sanadya J, Sharma P, Sharma K. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res. 2010;1(2):109.","journal-title":"J Adv Pharm Technol Res"},{"issue":"11","key":"24036_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"24036_CR15","unstructured":"Wells G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. http:\/\/www.ohrica\/programs\/clinical_epidemiology oxford htm 2004."},{"issue":"7414","key":"24036_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"6","key":"24036_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.295.6.676","volume":"295","author":"JL Peters","year":"2006","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676\u201380.","journal-title":"JAMA"},{"issue":"6","key":"24036_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4174\/astr.2021.101.6.315","volume":"101","author":"SJ Ahn","year":"2021","unstructured":"Ahn SJ, Yoon CI, Paik PS, Yoo T-K, Park N, Lee ES, Choi JE, Jeong J, Youn HJ, Park W-C. Analysis of risk factors associated with survival in human epidermal growth factor receptor 2-positive ductal carcinoma in situ using Korean breast Cancer society database. Annals Surg Treat Res. 2021;101(6):315\u201321.","journal-title":"Annals Surg Treat Res"},{"key":"24036_CR19","doi-asserted-by":"crossref","unstructured":"Areri HA, Shibabaw W, Mulugeta T, Asmare Y, Yirga T. Survival status and predictors of mortality among Breast Cancer patients in Adult Oncology Unit at Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2018. View Publ Site. 2019.","DOI":"10.1101\/636431"},{"issue":"1","key":"24036_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40615-020-00766-y","volume":"8","author":"OA Babatunde","year":"2021","unstructured":"Babatunde OA, Eberth JM, Felder T, Moran R, Truman S, Hebert JR, Zhang J, Adams SA. Social determinants of Racial disparities in breast cancer mortality among black and white women. J Racial Ethnic Health Disparities. 2021;8(1):147\u201356.","journal-title":"J Racial Ethnic Health Disparities"},{"issue":"4","key":"24036_CR21","doi-asserted-by":"publisher","first-page":"e00532","DOI":"10.34172\/jrhs.2021.65","volume":"21","author":"RH Bacha","year":"2021","unstructured":"Bacha RH, Jabir YN, Asebot AG, Liga AD. Risk factors affecting survival time of breast cancer patients: the case of Southwest Ethiopia. J Res Health Sci. 2021;21(4):e00532.","journal-title":"J Res Health Sci"},{"issue":"1","key":"24036_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-021-00294-w","volume":"7","author":"D Boyce-Fappiano","year":"2021","unstructured":"Boyce-Fappiano D, Bedrosian I, Shen Y, Lin H, Gjyshi O, Yoder A, Shaitelman S, Woodward W. Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer database analysis. NPJ Breast Cancer. 2021;7(1):1\u20139.","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"24036_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10549-009-0603-y","volume":"121","author":"A Emaus","year":"2010","unstructured":"Emaus A, Veier\u00f8d MB, Tretli S, Finstad SE, Selmer R, Furberg A-S, Bernstein L, Schlichting E, Thune I. Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat. 2010;121(3):651\u201360.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"24036_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01797-2","volume":"18","author":"M Escala-Garcia","year":"2020","unstructured":"Escala-Garcia M, Morra A, Canisius S, Chang-Claude J, Kar S, Zheng W, Bojesen SE, Easton D, Pharoah PD, Schmidt MK. Breast cancer risk factors and their effects on survival: a mendelian randomisation study. BMC Med. 2020;18(1):1\u201310.","journal-title":"BMC Med"},{"key":"24036_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1590\/0100-69912017005003","volume":"44","author":"RD Freitas Rd, Nunes","year":"2017","unstructured":"Freitas Rd, Nunes RD, Martins E, Curado MP, Freitas NMA, Soares LR, Oliveira JC. Prognostic factors and overall survival of breast cancer in the city of Goi\u00e2nia, Brazil: a population-based study. Rev Col\u00e9gio Bras Cir. 2017;44:435\u201343.","journal-title":"Rev Col\u00e9gio Bras Cir"},{"issue":"1","key":"24036_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1590\/1413-81232018241.35422016","volume":"24","author":"RHP Fujimoto","year":"2019","unstructured":"Fujimoto RHP, Koifman RJ, Silva, IFd. Sobrevida do c\u00e2ncer de Mama e fatores preditivos: Um Estudo de base hospitalar do Oeste amaz\u00f4nico, Brasil. Ci\u00eanc Sa\u00fade Coletiva. 2019;24(1):261\u201373.","journal-title":"Ci\u00eanc Sa\u00fade Coletiva"},{"issue":"11","key":"24036_CR27","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/ijc.30413","volume":"140","author":"W He","year":"2017","unstructured":"He W, Lindstr\u00f6m Sofie L, Hall P, Czene K. Cause-specific mortality in women with breast cancer in situ. Int J Cancer. 2017;140(11):2414\u201321.","journal-title":"Int J Cancer"},{"issue":"5","key":"24036_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/CEJ.0b013e32833b4828","volume":"19","author":"SS Hellmann","year":"2010","unstructured":"Hellmann SS, Thygesen LC, Tolstrup JS, Gr\u00f8nb\u00e6k M. Modifiable risk factors and survival in women diagnosed with primary breast cancer. Eur J Cancer Prev. 2010;19(5):366\u201373.","journal-title":"Eur J Cancer Prev"},{"issue":"7","key":"24036_CR29","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.18632\/aging.102984","volume":"12","author":"F Ji","year":"2020","unstructured":"Ji F, Yang C-Q, Li X-L, Zhang L-L, Yang M, Li J-Q, Gao H-F, Zhu T, Cheng M-Y, Li W-P. Risk of breast cancer-related death in women with a prior cancer. Aging. 2020;12(7):5894.","journal-title":"Aging"},{"issue":"1","key":"24036_CR30","first-page":"103","volume":"23","author":"SY Jung","year":"2012","unstructured":"Jung SY, Rosenzweig M, Sereika SM, Linkov F, Brufsky A, Weissfeld JL. Factors associated with mortality after breast cancer metastasis. Cancer Causes Control. 2012;23(1):103\u201312.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"24036_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4076-4","volume":"18","author":"A Lafourcade","year":"2018","unstructured":"Lafourcade A, His M, Baglietto L, Boutron-Ruault M-C, Dossus L, Rondeau V. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort. BMC Cancer. 2018;18(1):1\u20139.","journal-title":"BMC Cancer"},{"issue":"19","key":"24036_CR32","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.3390\/cancers14194565","volume":"14","author":"Y-C Lai","year":"2022","unstructured":"Lai Y-C, Chen Y-H, Wu Y-C, Liang F-W, Wang J-J, Lim S-W, Ho C-H. The association between smoking and mortality in women with breast cancer: a real-world database analysis. Cancers. 2022;14(19):4565.","journal-title":"Cancers"},{"issue":"5","key":"24036_CR33","doi-asserted-by":"publisher","first-page":"e0232581","DOI":"10.1371\/journal.pone.0232581","volume":"15","author":"KN Lee","year":"2020","unstructured":"Lee KN, Torres MA, Troeschel AN, He J, Gogineni K, McCullough LE. Type 2 diabetes, breast cancer specific and overall mortality: associations by metformin use and modification by race, body mass, and estrogen receptor status. PLoS One. 2020;15(5):e0232581.","journal-title":"PLoS One"},{"issue":"2","key":"24036_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10549-022-06674-5","volume":"195","author":"L McVicker","year":"2022","unstructured":"McVicker L, Cardwell CR, McIntosh SA, McMenamin \u00daC. Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study. Breast Cancer Res Treat. 2022;195(2):209\u201321.","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"24036_CR35","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1002\/cncr.25370","volume":"116","author":"LK Mell","year":"2010","unstructured":"Mell LK, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ. Predictors of competing mortality in early breast cancer. Cancer. 2010;116(23):5365\u201373.","journal-title":"Cancer"},{"issue":"3","key":"24036_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-018-4932-6","volume":"172","author":"AH Moore","year":"2018","unstructured":"Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness DJ, Hampton J, Wu X-C, Anderson RT, Lipscomb J. Obesity and mortality after locoregional breast cancer diagnosis. Breast Cancer Res Treat. 2018;172(3):647\u201357.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"24036_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015;1(7):888\u201396.","journal-title":"JAMA Oncol"},{"issue":"22","key":"24036_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192215335","volume":"19","author":"MN Nik Ab Kadir","year":"2022","unstructured":"Nik Ab Kadir MN, Yaacob NM, Yusof SN, Ab Hadi IS, Musa KI, Mohd Isa SA, Bahtiar B, Adam F, Yahya MM, Hairon SM. Development of predictive models for survival among women with breast cancer in Malaysia. Int J Environ Res Public Health. 2022;19(22): 15335.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"24036_CR39","first-page":"497","volume":"19","author":"N Nordin","year":"2018","unstructured":"Nordin N, Yaacob NM, Abdullah NH, Hairon SM. Survival time and prognostic factors for breast cancer among women in north-east Peninsular Malaysia. Asian Pac J Cancer Prevention: APJCP. 2018;19(2):497.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"1","key":"24036_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00536-7","volume":"7","author":"E Paredes-Aracil","year":"2017","unstructured":"Paredes-Aracil E, Palaz\u00f3n-Bru A, Folgado-de la Rosa DM, Ots-Guti\u00e9rrez JR, Compa\u00f1-Rosique AF. Gil-Guill\u00e9n VF: A scoring system to predict breast cancer mortality at 5 and 10 years. Sci Rep. 2017;7(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"5","key":"24036_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.15537\/smj.2020.5.25065","volume":"41","author":"O Pasin","year":"2020","unstructured":"Pasin O, Dirican A, Ankarali H, Disci R, Karanlik H. Assessment of death risk of breast cancer patients with joint frailty models. Saudi Med J. 2020;41(5):491.","journal-title":"Saudi Med J"},{"issue":"12","key":"24036_CR42","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1200\/JCO.2015.63.9328","volume":"34","author":"MN Passarelli","year":"2016","unstructured":"Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, Baron JA, Willett WC. Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases. J Clin Oncol. 2016;34(12):1315.","journal-title":"J Clin Oncol"},{"issue":"3","key":"24036_CR43","first-page":"131","volume":"2","author":"AE Seedhom","year":"2011","unstructured":"Seedhom AE, Kamal NN. Factors affecting survival of women diagnosed with breast cancer in El-Minia governorate, Egypt. Int J Prev Med. 2011;2(3):131.","journal-title":"Int J Prev Med"},{"issue":"5","key":"24036_CR44","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.puhe.2015.02.008","volume":"129","author":"S Seneviratne","year":"2015","unstructured":"Seneviratne S, Campbell I, Scott N, Lawrenson R, Shirley R, Elwood J. Risk factors associated with mortality from breast cancer in Waikato, New Zealand: a case-control study. Public Health. 2015;129(5):549\u201354.","journal-title":"Public Health"},{"issue":"1","key":"24036_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/1055-9965.EPI-17-0439","volume":"27","author":"S Shao","year":"2018","unstructured":"Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, Zhu K. Diabetes and overall survival among breast cancer patients in the US military health system. Cancer Epidemiol Biomarkers Prev. 2018;27(1):50\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"24036_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-23683-y","volume":"12","author":"N-C Shih","year":"2022","unstructured":"Shih N-C, Kung P-T, Kuo W-Y, Tsai W-C. Association of treatment delay and stage with mortality in breast cancer: a nationwide cohort study in Taiwan. Sci Rep. 2022;12(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"2","key":"24036_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-018-5002-9","volume":"173","author":"V Sopik","year":"2019","unstructured":"Sopik V, Sun P, Narod SA. Predictors of time to death after distant recurrence in breast cancer patients. Breast Cancer Res Treat. 2019;173(2):465\u201374.","journal-title":"Breast Cancer Res Treat"},{"key":"24036_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011220","author":"L Sun","year":"2018","unstructured":"Sun L, Zhu Y, Qian Q, Tang L. Body mass index and prognosis of breast cancer: an analysis by menstruation status when breast cancer diagnosis. Medicine (Baltimore). 2018. https:\/\/doi.org\/10.1097\/MD.0000000000011220.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"24036_CR49","doi-asserted-by":"publisher","first-page":"1908648","DOI":"10.1080\/2331205X.2021.1908648","volume":"8","author":"B Tesfay","year":"2021","unstructured":"Tesfay B, Getinet T, Derso EA. Survival analysis of time to death of breast Cancer patients: in case of ayder comprehensive specialized hospital tigray, Ethiopia. Cogent Med. 2021;8(1):1908648.","journal-title":"Cogent Med"},{"issue":"22","key":"24036_CR50","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1001\/archinte.166.22.2469","volume":"166","author":"JA Tice","year":"2006","unstructured":"Tice JA, Kanaya A, Hue T, Rubin S, Buist DS, LaCroix A, Lacey JV, Cauley JA, Litwack S, Brinton LA. Risk factors for mortality in middle-aged women. Arch Intern Med. 2006;166(22):2469\u201377.","journal-title":"Arch Intern Med"},{"key":"24036_CR51","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S339988","volume":"13","author":"M Tiruneh","year":"2021","unstructured":"Tiruneh M, Tesfaw A, Tesfa D. Survival and predictors of mortality among breast cancer patients in Northwest Ethiopia: a retrospective cohort study. Cancer Manag Res. 2021;13: 9225.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"24036_CR52","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1634\/theoncologist.2016-0369","volume":"22","author":"I Vaz-Luis","year":"2017","unstructured":"Vaz-Luis I, Lin NU, Keating NL, Barry WT, Winer EP, Freedman RA. Factors associated with early mortality among patients with de novo metastatic breast cancer: a population\u2010based study. Oncologist. 2017;22(4):386\u201393.","journal-title":"Oncologist"},{"issue":"8","key":"24036_CR53","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1158\/1055-9965.EPI-05-0106","volume":"14","author":"MK Whiteman","year":"2005","unstructured":"Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2005;14(8):2009\u201314.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"24036_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79166-5","volume":"10","author":"S-G Wu","year":"2020","unstructured":"Wu S-G, Yang S-P, Zhang W-W, Wang J, Lian C-L, Chen Y-X, He Z-Y. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma. Sci Rep. 2020;10(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"1","key":"24036_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-021-00245-5","volume":"6","author":"SX Yang","year":"2022","unstructured":"Yang SX, Hewitt SM, Yu J. Locoregional tumor burden and risk of mortality in metastatic breast cancer. NPJ Precis Oncol. 2022;6(1):1\u20137.","journal-title":"NPJ Precis Oncol"},{"issue":"5","key":"24036_CR56","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/ERC-17-0502","volume":"25","author":"M Zhang","year":"2018","unstructured":"Zhang M, Peng P, Gu K, Cai H, Qin G, Shu XO, Bao P. Time-varying effects of prognostic factors associated with long-term survival in breast cancer. Endocrine-related Cancer. 2018;25(5):509\u201321.","journal-title":"Endocrine-related Cancer"},{"key":"24036_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-018-1345-2","volume":"16","author":"SO Azubuike","year":"2018","unstructured":"Azubuike SO, Muirhead C, Hayes L, McNally R. Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol. 2018;16:1\u201313.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"24036_CR58","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Breast cancer statistics, 2019. Cancer J Clin. 2019;69(6):438\u201351.","journal-title":"Cancer J Clin"},{"issue":"40","key":"24036_CR59","doi-asserted-by":"publisher","first-page":"65024","DOI":"10.18632\/oncotarget.11344","volume":"7","author":"Z-h Li","year":"2016","unstructured":"Li Z-h, Hu P-h, Tu J-h, Yu N-s. Luminal B breast cancer: patterns of recurrence and clinical outcome. Oncotarget. 2016;7(40):65024.","journal-title":"Oncotarget"},{"issue":"2","key":"24036_CR60","doi-asserted-by":"publisher","first-page":"104154","DOI":"10.1016\/j.esmoop.2025.104154","volume":"10","author":"S Lammers","year":"2025","unstructured":"Lammers S, Geurts S, Hermans K, Kooreman L, Swinkels A, Smorenburg C, van der Sangen M, Kroep J, Honkoop A, van den Berkmortel F. The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial. ESMO Open. 2025;10(2):104154.","journal-title":"ESMO Open"},{"issue":"5","key":"24036_CR61","doi-asserted-by":"publisher","first-page":"e2313989","DOI":"10.1001\/jamanetworkopen.2023.13989","volume":"6","author":"S Obeng-Gyasi","year":"2023","unstructured":"Obeng-Gyasi S, Elsaid MI, Lu Y, Chen J, Carson WE, Ballinger TJ, Andersen BL. Association of allostatic load with all-cause mortality in patients with breast cancer. JAMA Netw Open. 2023;6(5):e2313989-2313989.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"24036_CR62","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1099800420969898","volume":"23","author":"A Mathew","year":"2021","unstructured":"Mathew A, Doorenbos AZ, Li H, Jang MK, Park CG, Bronas UG. Allostatic load in cancer: a systematic review and mini meta-analysis. Biol Res Nurs. 2021;23(3):341\u201361.","journal-title":"Biol Res Nurs"},{"issue":"2","key":"24036_CR63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/aac2.12064","volume":"4","author":"D Yang","year":"2023","unstructured":"Yang D, Wheeler M, Karanth SD, Aduse-Poku L, Leeuwenburgh C, Anton S, Guo Y, Bian J, Liang M, Yoon HS. Allostatic load and risk of all\u2010cause, cancer\u2010specific, and cardiovascular mortality in older cancer survivors: an analysis of the National health and nutrition examination survey 1999\u20132010. Aging Cancer. 2023;4(2):74\u201384.","journal-title":"Aging Cancer"},{"issue":"8","key":"24036_CR64","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1056\/NEJMoa1413513","volume":"372","author":"SM Swain","year":"2015","unstructured":"Swain SM, Baselga J, Kim S-B, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero J-M, Schneeweiss A, Heeson S. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med. 2015;372(8):724\u201334.","journal-title":"N Engl J Med"},{"issue":"13","key":"24036_CR65","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1200\/JCO.20.01204","volume":"39","author":"M Piccart","year":"2021","unstructured":"Piccart M, Procter M, Fumagalli D, de Azambuja E, Clark E, Ewer MS, Restuccia E, Jerusalem G, Dent S, Reaby L. Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years\u2019 follow-up. J Clin Oncol. 2021;39(13):1448\u201357.","journal-title":"J Clin Oncol"},{"issue":"8","key":"24036_CR66","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1470-2045(21)00288-6","volume":"22","author":"R Bradley","year":"2021","unstructured":"Bradley R, Braybrooke J, Gray R, Hills R, Liu Z, Peto R, Davies L, Dodwell D, McGale P, Pan H. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials. Lancet Oncol. 2021;22(8):1139\u201350.","journal-title":"Lancet Oncol"},{"issue":"11","key":"24036_CR67","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R, Engels EA. Spectrum of cancer risk among HIV-infected people in the united States during the modern antiretroviral therapy era: a population-based registry linkage study. Lancet HIV. 2017;4(11):e495.","journal-title":"Lancet HIV"},{"key":"24036_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.breast.2022.08.001","volume":"65","author":"MP Ferreira","year":"2022","unstructured":"Ferreira MP, Thuler LCS, Soares MA, Soares EA, Bergmann A. Survival in HIV\u2009+\u2009and HIV\u2013\u2009women with breast cancer treated at the National Cancer Institute in the City of Rio de janeiro, brazil, between 2000 and 2014. Breast. 2022;65:151\u20136.","journal-title":"Breast"},{"issue":"2","key":"24036_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ijc.33981","volume":"151","author":"OA Ayeni","year":"2022","unstructured":"Ayeni OA, O\u2019Neil DS, Pumpalova YS, Chen WC, Nietz S, Phakathi B, Buccimazza I, \u010ca\u010dala S, Stopforth LW, Farrow HA. Impact of HIV infection on survival among women with stage I-III breast cancer: results from the South African breast cancer and HIV outcomes study. Int J Cancer. 2022;151(2):209\u201321.","journal-title":"Int J Cancer"},{"key":"24036_CR70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7607","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015. https:\/\/doi.org\/10.1136\/bmj.g7607.","journal-title":"BMJ"},{"issue":"1","key":"24036_CR71","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2002.20.1.42","volume":"20","author":"PJ Goodwin","year":"2002","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002;20(1):42\u201351.","journal-title":"J Clin Oncol"},{"issue":"4","key":"24036_CR72","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/dc17-2012","volume":"41","author":"IC Lega","year":"2018","unstructured":"Lega IC, Austin PC, Fischer HD, Fung K, Krzyzanowska MK, Amir E, Lipscombe LL. The impact of diabetes on breast cancer treatments and outcomes: a population-based study. Diabetes Care. 2018;41(4):755\u201361.","journal-title":"Diabetes Care"},{"issue":"4","key":"24036_CR73","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/cancers7040883","volume":"7","author":"DP Rose","year":"2015","unstructured":"Rose DP, Gracheck PJ, Vona-Davis L. The interactions of obesity, inflammation and insulin resistance in breast cancer. Cancers. 2015;7(4):2147\u201368.","journal-title":"Cancers"},{"issue":"11","key":"24036_CR74","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/jnci\/djab023","volume":"113","author":"AE Lohmann","year":"2021","unstructured":"Lohmann AE, Soldera SV, Pimentel I, Ribnikar D, Ennis M, Amir E, Goodwin PJ. Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis. JNCI: J Natl Cancer Inst. 2021;113(11):1465\u201375.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"24036_CR75","doi-asserted-by":"crossref","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid R. Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management. Cancers. 2023:15(2):485.","DOI":"10.3390\/cancers15020485"},{"key":"24036_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3611-z","volume":"17","author":"H Goldvaser","year":"2017","unstructured":"Goldvaser H, Gal O, Rizel S, Hendler D, Neiman V, Shochat T, Sulkes A, Brenner B, Yerushalmi R. The association between smoking and breast cancer characteristics and outcome. BMC Cancer. 2017;17:1\u20138.","journal-title":"BMC Cancer"},{"key":"24036_CR77","doi-asserted-by":"crossref","unstructured":"Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: A narrative review. Tob Induc Dis. 2020:18:60.","DOI":"10.18332\/tid\/123845"},{"issue":"4","key":"24036_CR78","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaoncol.2022.7705","volume":"9","author":"KF Hoskins","year":"2023","unstructured":"Hoskins KF, Calip GS, Huang H-C, Ibraheem A, Danciu OC, Rauscher GH. Association of social determinants and tumor biology with racial disparity in survival from early-stage, hormone-dependent breast cancer. JAMA Oncol. 2023;9(4):536\u201345.","journal-title":"JAMA Oncol"},{"issue":"10","key":"24036_CR79","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jacr.2021.06.019","volume":"18","author":"JM Miller-Kleinhenz","year":"2021","unstructured":"Miller-Kleinhenz JM, Collin LJ, Seidel R, Reddy A, Nash R, Switchenko JM, McCullough LE. Racial disparities in diagnostic delay among women with breast cancer. J Am Coll Radiol. 2021;18(10):1384\u201393.","journal-title":"J Am Coll Radiol"},{"key":"24036_CR80","first-page":"149","volume":"30","author":"BR Hunt","year":"2019","unstructured":"Hunt BR, Silva A, Lock D, Hurlbert M. Predictors of breast cancer mortality among white and black women in large United States cities: an ecologic study. Cancer Causes Control. 2019;30:149\u201364.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"24036_CR81","first-page":"1","volume":"3","author":"AC Mensah","year":"2016","unstructured":"Mensah AC, Yarney J, Nokoe SK, Opoku S, Clegg-Lamptey J. Survival outcomes of breast cancer in Ghana: an analysis of clinicopathological features. Open Access Libr J. 2016;3(1):1\u201311.","journal-title":"Open Access Libr J"},{"issue":"1","key":"24036_CR82","first-page":"4","volume":"6","author":"MH Pham","year":"2014","unstructured":"Pham MH. Survival analysis-Breast cancer. Undergrad J Math Modeling: One + Two. 2014;6(1):4.","journal-title":"Undergrad J Math Modeling: One + Two"},{"issue":"6","key":"24036_CR83","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jama.2012.84","volume":"307","author":"W van de Water","year":"2012","unstructured":"van de Water W, Markopoulos C, van de Velde CJ, Seynaeve C, Hasenburg A, Rea D, Putter H, Nortier JW, de Craen AJ, Hille ET. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor\u2013positive breast cancer. JAMA. 2012;307(6):590\u20137.","journal-title":"JAMA"},{"issue":"1","key":"24036_CR84","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/eurpub\/ckw148","volume":"27","author":"CB Trewin","year":"2017","unstructured":"Trewin CB, Strand BH, Weedon-Fekj\u00e6r H, Ursin G. Changing patterns of breast cancer incidence and mortality by education level over four decades in Norway, 1971\u20132009. Eur J Public Health. 2017;27(1):160\u20136.","journal-title":"Eur J Public Health"},{"issue":"12","key":"24036_CR85","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/ijc.27538","volume":"131","author":"S Gadeyne","year":"2012","unstructured":"Gadeyne S, Deboosere P, Vandenheede H, Neels K. Does birth history account for educational differences in breast cancer mortality? A comparison of premenopausal and postmenopausal women in Belgium. Int J Cancer. 2012;131(12):2878\u201385.","journal-title":"Int J Cancer"},{"issue":"1","key":"24036_CR86","doi-asserted-by":"publisher","first-page":"18860","DOI":"10.3402\/gha.v6i0.18860","volume":"6","author":"N Lan","year":"2013","unstructured":"Lan N, Laohasiriwong W, Stewart J. Survival probability and prognostic factors for breast cancer patients in Vietnam. Glob Health Action. 2013;6(1):18860.","journal-title":"Glob Health Action"},{"issue":"9472","key":"24036_CR87","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"EBCTC Group","year":"2005","unstructured":"Group EBCTC. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687\u2013717.","journal-title":"Lancet"},{"issue":"3","key":"24036_CR88","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.amjsurg.2008.11.014","volume":"197","author":"SF Sener","year":"2009","unstructured":"Sener SF, Winchester DJ, Winchester DP, Du H, Barrera E, Bilimoria M, Krantz S, Rabbitt S. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival. Am J Surg. 2009;197(3):403\u20137.","journal-title":"Am J Surg"},{"issue":"4","key":"24036_CR89","first-page":"273","volume":"173","author":"J Crowe Jr","year":"1991","unstructured":"Crowe J Jr, Gordon N, Hubay C, Shenk R, Zollinger R, Brumberg D, McGuire W, Shuck J. Estrogen receptor determination and long term survival of patients with carcinoma of the breast. Surg Gynecol Obstet. 1991;173(4):273\u20138.","journal-title":"Surg Gynecol Obstet"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24036-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24036-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24036-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:00:33Z","timestamp":1757340033000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24036-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24036"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24036-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participants"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2640"}}